YU174491A - Vakcine - Google Patents
VakcineInfo
- Publication number
- YU174491A YU174491A YU174491A YU174491A YU174491A YU 174491 A YU174491 A YU 174491A YU 174491 A YU174491 A YU 174491A YU 174491 A YU174491 A YU 174491A YU 174491 A YU174491 A YU 174491A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- vaccines
- immunotherapeutic
- mpl
- supplemented
- preparations
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000001759 immunoprophylactic effect Effects 0.000 abstract 1
- 230000001024 immunotherapeutic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919106048A GB9106048D0 (en) | 1991-03-21 | 1991-03-21 | Vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU174491A true YU174491A (sh) | 1994-06-10 |
Family
ID=10691984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU174491A YU174491A (sh) | 1991-03-21 | 1991-11-01 | Vakcine |
Country Status (12)
| Country | Link |
|---|---|
| CN (1) | CN1064891A (fr) |
| AP (1) | AP368A (fr) |
| BR (1) | BR9107294A (fr) |
| CZ (1) | CZ195793A3 (fr) |
| FI (1) | FI934133A (fr) |
| GB (1) | GB9106048D0 (fr) |
| HU (2) | HU9302642D0 (fr) |
| IL (1) | IL99899A0 (fr) |
| MA (1) | MA22381A1 (fr) |
| SK (1) | SK82593A3 (fr) |
| WO (1) | WO1992016556A1 (fr) |
| YU (1) | YU174491A (fr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9105992D0 (en) * | 1991-03-21 | 1991-05-08 | Smithkline Beecham Biolog | Vaccine |
| US6620414B2 (en) | 1992-03-27 | 2003-09-16 | Smithkline Beecham Biologicals (S.A.) | Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A |
| ATE157882T1 (de) * | 1993-03-23 | 1997-09-15 | Smithkline Beecham Biolog | 3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| GB9706957D0 (en) | 1997-04-05 | 1997-05-21 | Smithkline Beecham Plc | Formulation |
| GB9820525D0 (en) | 1998-09-21 | 1998-11-11 | Allergy Therapeutics Ltd | Formulation |
| GB0000891D0 (en) | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
| CN1304580C (zh) * | 2004-07-09 | 2007-03-14 | 楼伟 | 重组表达人获得性免疫缺陷病毒I型的表面糖蛋白gp160 |
| EP1778725B1 (fr) * | 2004-07-23 | 2010-12-29 | Novartis Vaccines and Diagnostics S.r.l. | Polypeptides pour assemblage oligomere d'antigenes |
| CN102657855B (zh) | 2004-09-22 | 2015-12-09 | 葛兰素史密丝克莱恩生物有限公司 | 用于进行抗葡萄球菌接种的免疫原性组合物 |
| WO2008104803A2 (fr) | 2007-02-26 | 2008-09-04 | Oxford Genome Sciences (Uk) Limited | Protéines |
| EP2121745A2 (fr) | 2007-02-26 | 2009-11-25 | Oxford Genome Sciences (UK) Limited | Protéines |
| JP2012515544A (ja) | 2009-01-21 | 2012-07-12 | オックスフォード ビオトヘラペウトイクス エルティーディー． | Ｐｔａ０８９タンパク質 |
| EP2496605A1 (fr) | 2009-11-02 | 2012-09-12 | Oxford Biotherapeutics Ltd. | Ror1 comme cible thérapeutique et diagnostique |
| RS55716B1 (sr) | 2011-06-28 | 2017-07-31 | Oxford Biotherapeutics Ltd | Terapeutski i dijagnostički cilj |
| GB201213364D0 (en) | 2012-07-27 | 2012-09-12 | Glaxosmithkline Biolog Sa | Purification process |
| GB201213652D0 (en) | 2012-08-01 | 2012-09-12 | Oxford Biotherapeutics Ltd | Therapeutic and diagnostic target |
| GB201302447D0 (en) | 2013-02-12 | 2013-03-27 | Oxford Biotherapeutics Ltd | Therapeutic and diagnostic target |
| US20180071380A1 (en) | 2015-03-20 | 2018-03-15 | The Regents Of The University Of Michigan | Immunogenic compositions for use in vaccination against bordetella |
| CA3023672A1 (fr) | 2016-05-16 | 2017-11-23 | Infectious Disease Research Institute | Liposomes pegyles et procedes d'utilisation |
| US11344619B2 (en) | 2016-05-16 | 2022-05-31 | Access To Advanced Health Institute | Formulation containing TLR agonist and methods of use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL89567A0 (en) * | 1988-03-28 | 1989-09-10 | Univ Leland Stanford Junior | Mutated hiv envelope protein |
-
1991
- 1991-03-21 GB GB919106048A patent/GB9106048D0/en active Pending
- 1991-10-25 SK SK825-93A patent/SK82593A3/sk unknown
- 1991-10-25 BR BR9107294A patent/BR9107294A/pt not_active Application Discontinuation
- 1991-10-25 WO PCT/EP1991/002047 patent/WO1992016556A1/fr not_active Application Discontinuation
- 1991-10-25 HU HU9302642A patent/HU9302642D0/hu unknown
- 1991-10-25 HU HU9302642A patent/HUT67011A/hu unknown
- 1991-10-30 IL IL99899A patent/IL99899A0/xx unknown
- 1991-11-01 YU YU174491A patent/YU174491A/sh unknown
- 1991-11-04 AP APAP/P/1991/000332A patent/AP368A/en active
- 1991-11-09 CN CN91111514.5A patent/CN1064891A/zh active Pending
- 1991-12-30 MA MA22665A patent/MA22381A1/fr unknown
-
1993
- 1993-09-21 FI FI934133A patent/FI934133A/fi not_active Application Discontinuation
- 1993-10-25 CZ CZ931957A patent/CZ195793A3/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB9106048D0 (en) | 1991-05-08 |
| CN1064891A (zh) | 1992-09-30 |
| HU9302642D0 (en) | 1994-01-28 |
| HUT67011A (en) | 1995-01-30 |
| WO1992016556A1 (fr) | 1992-10-01 |
| CZ195793A3 (en) | 1994-05-18 |
| MA22381A1 (fr) | 1992-07-01 |
| AP9100332A0 (en) | 1992-01-31 |
| IL99899A0 (en) | 1992-08-18 |
| SK82593A3 (en) | 1994-01-12 |
| BR9107294A (pt) | 1994-06-14 |
| FI934133A0 (fi) | 1993-09-21 |
| FI934133A (fi) | 1993-09-21 |
| AP368A (en) | 1994-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU174491A (sh) | Vakcine | |
| UA40597C2 (uk) | Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів | |
| ITFI920058A1 (it) | Composti coniugati formati da proteine heat shock (hsp) e oligo-polisaccaridi, loro uso per la produzione di vaccini. | |
| DE69620877T2 (de) | Arzneimittelformulierungen für il-12 | |
| AU1955088A (en) | Avirulent microbes, incapable of producing functional adenylate cyclase and cyclic AMP | |
| TR199802329T2 (xx) | Enfeksiyon hastal�klar�n�n tedavisinde IL-12 ve IFNalfa kullan�m�. | |
| HUP9801242A1 (hu) | Hepatitis B vakcina | |
| NO941786L (no) | Uretaner og ureaer som induserer cytokinproduksjon | |
| DK0951473T3 (da) | Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette | |
| NL300183I1 (nl) | Acellulair vaccin. | |
| PT97905A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo derivados da cistina | |
| PT789590E (pt) | Imunopotenciacao induzida por quitosano | |
| DE69636285D1 (de) | ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF | |
| GR920100570A (el) | Παραγωγα 3(2η)-πυριδαζινονης και μεθοδος για την παρασκευη τους. | |
| DE69414810D1 (de) | Rapamycin-Zubereitungen zur oralen Verabreichung | |
| PT600396E (pt) | Vacinas contra protozoarios intestinais | |
| WO1992006113A3 (fr) | DERIVES DE gp160 ET VACCINS A BASE DE gp160 OU D'UN DE SES DERIVES, CONTENANT UN ADJUVANT | |
| ES2159287T3 (es) | Peptidos hemorreguladores. | |
| ATE318300T1 (de) | Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe | |
| NO933628L (no) | Fremgangsmaate og blanding for behandling av Herpes-infeksjoner | |
| NO933342L (no) | Derivater av gp160 og vaksiner basert paa gp160 eller et derivat derav, inneholdende et adjuvans | |
| BG102083A (en) | Compositions and methods for the detection and treatment of aids |